News
Cantor Fitzgerald Reiterates Overweight on Alumis
19 Aug 24
News, Reiteration, Analyst Ratings
Newly-Listed Psoriasis-Focused Alumis Attracts Analysts' Attention With Promising Lead Program And Modest Valuation
24 Jul 24
Analyst Color, Biotech, Equities, News, Health Care, Price Target, Initiation, Analyst Ratings, Trading Ideas, General
CORRECTION: Cantor Fitzgerald Initiates Coverage On Alumis with Overweight Rating (Originally Published on 23rd July)
24 Jul 24
News, Initiation, Analyst Ratings
Guggenheim Initiates Coverage On Alumis with Buy Rating, Announces Price Target of $32
23 Jul 24
News, Price Target, Initiation, Analyst Ratings
Cantor Fitzgerald Initiates Coverage On Alumis with Overweight Rating, Announces Price Target of $13
23 Jul 24
News, Price Target, Initiation, Analyst Ratings
Leerink Partners Initiates Coverage On Alumis with Outperform Rating, Announces Price Target of $29
23 Jul 24
News, Price Target, Initiation, Analyst Ratings
Morgan Stanley Initiates Coverage On Alumis with Overweight Rating, Announces Price Target of $36
23 Jul 24
News, Price Target, Initiation, Analyst Ratings